
New neurokinin receptor antagonists such as fezolinetant and elinzanetant are reshaping treatment options for menopausal hot flashes.
Genevieve Neal-Perry, MD, PhD, is the Department Chair of Obstetrics and Gynecology at UNC School of Medicine.

New neurokinin receptor antagonists such as fezolinetant and elinzanetant are reshaping treatment options for menopausal hot flashes.